Phase II trial of MRX I in patients with complicated skin and skin structure infections in China
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2015
Price : $35 *
At a glance
- Drugs Contezolid (Primary) ; Linezolid
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors MicuRx Pharmaceuticals
- 31 Aug 2015 Status changed from recruiting to completed, according to a MicuRx Pharmaceuticals media release.
- 31 Aug 2015 Top-line results were published in a MicuRx Pharmaceuticals media release.
- 25 Feb 2015 Status changed from planning to recruiting, as reported in a MicuRx Pharmaceuticals media release.